Therapeutic drug monitoring.
作者信息
Bayer W H
出版信息
West J Med. 1986 Oct;145(4):524-7.
Abstract
摘要
相似文献
1
Therapeutic drug monitoring.治疗药物监测
West J Med. 1986 Oct;145(4):524-7.
2
Clinical relevance of pharmacokinetics.药代动力学的临床相关性。
Clin Pharmacokinet. 1980 Mar-Apr;5(2):105-36. doi: 10.2165/00003088-198005020-00001.
3
Plasma drug levels as an aid to medical treatment.血浆药物浓度辅助医疗治疗。
Ir Med J. 1984 Jan;77(1):23-6.
4
Clinical and professional reference guides. Critical values for therapeutic drug levels.
MLO Med Lab Obs. 2001 Aug;33(8 Suppl):15.
5
[Drug therapy in liver diseases: problems in intensive care].[肝脏疾病的药物治疗：重症监护中的问题]
Schweiz Med Wochenschr. 1986 Apr 26;116(17):549-52.
6
Plasma concentrations of drugs as a guide to therapy in clinical practice.
Ir Med J. 1978 Nov 30;71(17):578-82.
7
Use of limited laboratory-acquired therapeutic drug monitoring data in determining individualized drug requirements.利用有限的实验室获得性治疗药物监测数据确定个体化药物需求。
Ann Clin Lab Sci. 1987 Jan-Feb;17(1):52-9.
8
[Interactions with cimetidine (author's transl)].与西咪替丁的相互作用（作者译）
Therapie. 1982 Jan-Feb;37(1):3-11.
9
[Effect of drugs on neonates, infants and school children. 2. Pharmacokinetics and pharmacodynamics].[药物对新生儿、婴儿及学龄儿童的影响。2. 药代动力学与药效学]
Fortschr Med. 1982 Feb 18;100(7):271-6.
10
[Determination of drug concentrations in body fluid; possibilities and limitations. II. Determination of plasma levels as a part of individual patient treatment].[体液中药物浓度的测定；可能性与局限性。II. 作为个体患者治疗一部分的血浆水平测定]
Ned Tijdschr Geneeskd. 1980 Jul 19;124(29):1201-12.
引用本文的文献
1
A National Survey of Attitudes and Practices of Physicians Relating to Therapeutic Drug Monitoring and Clinical Pharmacokinetic Service: Strategies for Enhancing Patient's Care in Saudi Arabia.沙特阿拉伯关于医生在治疗药物监测和临床药代动力学服务方面的态度与实践的全国性调查：改善患者护理的策略
Int J Gen Med. 2021 Apr 23;14:1513-1524. doi: 10.2147/IJGM.S296731. eCollection 2021.
本文引用的文献
1
Diagnostic decision. The measurement of anticonvulsant agent levels.诊断决策。抗惊厥药物水平的测定。
Ann Intern Med. 1984 Jun;100(6):854-8. doi: 10.7326/0003-4819-100-6-854.
2
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.氨基糖苷类血浆水平与革兰氏阴性菌血症患者死亡率的关联。
J Infect Dis. 1984 Mar;149(3):443-8. doi: 10.1093/infdis/149.3.443.
3
Serum digoxin concentration and diagnosis of digitalis toxicity. Current concepts.血清地高辛浓度与洋地黄毒性的诊断。当前概念
Clin Pharmacokinet. 1983 Jul-Aug;8(4):279-85. doi: 10.2165/00003088-198308040-00001.
4
Reliability of antiarrhythmic drug plasma concentration monitoring.抗心律失常药物血药浓度监测的可靠性
Clin Pharmacokinet. 1983 Jan-Feb;8(1):63-82. doi: 10.2165/00003088-198308010-00004.
5
Theophylline reassessed.茶碱再评估
Ann Intern Med. 1984 Jul;101(1):63-73. doi: 10.7326/0003-4819-101-1-63.
6
Drug therapy. Serum drug concentrations as therapeutic guides.药物治疗。作为治疗指导的血清药物浓度。
N Engl J Med. 1972 Aug 3;287(5):227-31. doi: 10.1056/NEJM197208032870505.
7
Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis.严重革兰氏阴性菌败血症治疗期间监测庆大霉素治疗的经验。
Br Med J. 1974 Mar 16;1(5906):477-81. doi: 10.1136/bmj.1.5906.477.
8
Choosing optimal sampling times for therapeutic drug monitoring.为治疗药物监测选择最佳采样时间。
Clin Pharm. 1985 Jan-Feb;4(1):84-92.
9
Association between clinical cardiac status, laboratory parameters, and digoxin usage.临床心脏状况、实验室参数与地高辛使用之间的关联。
Am Heart J. 1976 Jan;91(1):28-34. doi: 10.1016/s0002-8703(76)80431-0.
Zotero 插件